Cardiovascular Diseases, Insulin Resistance, Musculoskeletal Diseases, Non-Communicable Chronic Diseases, Obesity, Psychological Disorder
Conditions
Brief summary
Healthy Life Centers (Norwegian, 'Frisklivssentralen') is a municipal service in Norway that aims to promote both physical and mental health, as well as to limit the development of non-communicable diseases. Previous research has shown that receiving follow-up from Healthy Life Centers has led to higher levels of daily physical activity, in addition to improved self-reported health and quality of life among the participants. However, there is a lack of studies that have examined what kind of physiological health effects can be expected from participating in the Healthy Life Center's follow-up. In this study, responses to the 12-week physical activity program of the Healthy Life Center will be compared with the responses in a negative control group that does not receive such follow-up. Both the intervention group and the reference group (the negative control group) will carry out the same tests and measurements before and after the 12 week period. The tests will include measurements of anthropometric variables (body height, body weight and waist circumference), body composition, arterial stiffness, resting blood pressure and blood variables (blood glucose, long-term blood glucose, blood lipid profile and inflammation markers), in addition to physical tests of mobility, balance, maximum aerobic capacity (maximal oxygen consumption) and maximum muscle strength. Questionnaires related to adherence to the Healthy Life Center follow-up, socio-demographic variables, eating and drinking habits, activity level, perceived physical fitness, motivation for exercise, and health-related quality of life will also be included.
Interventions
OTHERPhysical activity
The participants will receive the possibility to attend weekly endurance, resistance and yoga exercise sessions administered by the Healthy Life Center. They will also receive personalized follow-up from the Healthy Life Center, and have the possibility to exercise at the local gym.
Sponsors
Inland Norway University of Applied Sciences
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Intervention group Inclusion Criteria: * \>18 years of age * Receiving follow-up from the Healthy Life Center
Exclusion criteria
* In average \>1 weekly exercise training session the last three months Reference group Inclusion Criteria: * \>18 years of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Maximal oxygen consumption (measured in mL/kg body mass/min) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cholesterol and total triglyceride levels (serum, fasted state) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Maximal muscle strength (measured in newtons produced during a leg press exercise) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Maximal muscle power (measured in watts produced during a leg press exercise) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Waist circumference | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Balance, measured using the single leg stance test (measured in seconds) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Mobility, measured using the sit-and-reach and the back stretch test (measured in centimeters) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Fat mass (measured in kilograms) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Lean mass (measured in kilograms) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Bone mineral density ( measured in g/cm2) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Visceral fat (measured in grams) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Blood glucose levels (serum, fasted state) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Resting blood pressure | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Systemic inflammation markers (levels of c-reactive protein, TNF-alpha, interleukin 6 and interleukin 8 in serum, fasted state) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Arterial stiffness | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Health-related quality of life (measured using the SF-36 questionnaire; scores from 0-100, where a higher score means a better outcome) | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Body mass index | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
Other
| Measure | Time frame | Description |
|---|---|---|
| Compliance to the 12-week intervention (measured as the number of sessions the participant conducted the session as prescribed divided by the number of total sessions) | During the 12-week intervention | For the intervention group |
| Activity level | From before to after the 12-week intervention/control period | Difference in change between the two study arms from before to after the 12-week intervention/control period |
| Adherence to the 12-week intervention (measured as the number of sessions the participant attended divided by the number of sessions prescribed) | During the 12-week intervention | For the intervention group |
Contacts
Primary ContactKnut Sindre Mølmen, PhD
Outcome results
None listed